Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 59

1.

Portfolios of biomedical HIV interventions in South Africa: a cost-effectiveness analysis.

Long EF, Stavert RR.

J Gen Intern Med. 2013 Oct;28(10):1294-301. doi: 10.1007/s11606-013-2417-1. Epub 2013 Apr 16.

2.

Where to deploy pre-exposure prophylaxis (PrEP) in sub-Saharan Africa?

Verguet S, Stalcup M, Walsh JA.

Sex Transm Infect. 2013 Dec;89(8):628-34. doi: 10.1136/sextrans-2012-050891. Epub 2013 Aug 2. Review.

PMID:
23912819
3.

The cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: a systematic review of cost-effectiveness modelling studies.

Gomez GB, Borquez A, Case KK, Wheelock A, Vassall A, Hankins C.

PLoS Med. 2013;10(3):e1001401. doi: 10.1371/journal.pmed.1001401. Epub 2013 Mar 12. Review.

4.

Cost-effectiveness of pre-exposure prophylaxis for HIV: a review.

Schackman BR, Eggman AA.

Curr Opin HIV AIDS. 2012 Nov;7(6):587-92. doi: 10.1097/COH.0b013e3283582c8b. Review.

PMID:
23076124
5.

The preexposure prophylaxis revolution; from clinical trials to programmatic implementation.

Mugo NR, Ngure K, Kiragu M, Irungu E, Kilonzo N.

Curr Opin HIV AIDS. 2016 Jan;11(1):80-6. doi: 10.1097/COH.0000000000000224. Review.

6.

Modeling and Cost-Effectiveness in HIV Prevention.

Jacobsen MM, Walensky RP.

Curr HIV/AIDS Rep. 2016 Feb;13(1):64-75. doi: 10.1007/s11904-016-0303-2. Review.

7.

Combination prevention: new hope for stopping the epidemic.

Vermund SH, Hayes RJ.

Curr HIV/AIDS Rep. 2013 Jun;10(2):169-86. doi: 10.1007/s11904-013-0155-y. Review.

8.

Cost-effectiveness of antiretroviral therapy for prevention.

Kahn JG, Marseille EA, Bennett R, Williams BG, Granich R.

Curr HIV Res. 2011 Sep;9(6):405-15. Review.

9.

Reviewing the evidence on effectiveness and cost-effectiveness of HIV prevention strategies in Thailand.

Pattanaphesaj J, Teerawattananon Y.

BMC Public Health. 2010 Jul 7;10:401. doi: 10.1186/1471-2458-10-401. Review.

10.

Antiretroviral-based HIV prevention strategies for women.

Chirenje ZM, Marrazzo J, Parikh UM.

Expert Rev Anti Infect Ther. 2010 Oct;8(10):1177-86. doi: 10.1586/eri.10.79. Review.

11.

Combination HIV prevention options for young women in Africa.

Baxter C, Abdool Karim S.

Afr J AIDS Res. 2016 Jul;15(2):109-21. doi: 10.2989/16085906.2016.1196224. Review.

PMID:
27399041
12.

Economic evaluations of adult male circumcision for prevention of heterosexual acquisition of HIV in men in sub-Saharan Africa: a systematic review.

Uthman OA, Popoola TA, Uthman MM, Aremu O.

PLoS One. 2010 Mar 10;5(3):e9628. doi: 10.1371/journal.pone.0009628. Review.

13.

Analytic review of modeling studies of ARV Based PrEP interventions reveals strong influence of drug-resistance assumptions on the population-level effectiveness.

Dimitrov D, Boily MC, Brown ER, Hallett TB.

PLoS One. 2013 Nov 25;8(11):e80927. doi: 10.1371/journal.pone.0080927. eCollection 2013. Review.

14.

The past, present, and future of HIV prevention: integrating behavioral, biomedical, and structural intervention strategies for the next generation of HIV prevention.

Rotheram-Borus MJ, Swendeman D, Chovnick G.

Annu Rev Clin Psychol. 2009;5:143-67. doi: 10.1146/annurev.clinpsy.032408.153530. Review.

15.

Adherence challenges with drugs for pre-exposure prophylaxis to prevent HIV infection.

Gengiah TN, Moosa A, Naidoo A, Mansoor LE.

Int J Clin Pharm. 2014 Feb;36(1):70-85. doi: 10.1007/s11096-013-9861-1. Epub 2013 Oct 16. Review.

16.

HIV prevention cost-effectiveness: a systematic review.

Galárraga O, Colchero MA, Wamai RG, Bertozzi SM.

BMC Public Health. 2009 Nov 18;9 Suppl 1:S5. doi: 10.1186/1471-2458-9-S1-S5. Review.

17.

The History of the HIV/AIDS Epidemic in Africa.

Kagaayi J, Serwadda D.

Curr HIV/AIDS Rep. 2016 Aug;13(4):187-93. doi: 10.1007/s11904-016-0318-8. Review.

PMID:
27188298
18.

Combination HIV prevention interventions: the potential of integrated behavioral and biomedical approaches.

Brown JL, Sales JM, DiClemente RJ.

Curr HIV/AIDS Rep. 2014 Dec;11(4):363-75. doi: 10.1007/s11904-014-0228-6. Review.

19.

Adherence support approaches in biomedical HIV prevention trials: experiences, insights and future directions from four multisite prevention trials.

Amico KR, Mansoor LE, Corneli A, Torjesen K, van der Straten A.

AIDS Behav. 2013 Jul;17(6):2143-55. doi: 10.1007/s10461-013-0429-9. Review.

20.

Voluntary medical male circumcision: an introduction to the cost, impact, and challenges of accelerated scaling up.

Hankins C, Forsythe S, Njeuhmeli E.

PLoS Med. 2011 Nov;8(11):e1001127. doi: 10.1371/journal.pmed.1001127. Epub 2011 Nov 29. Review.

Supplemental Content

Support Center